Carlos Martin

Carlos Martin is a Board Member at NKILT Therapeutics, a cell therapy biotech company developing novel approaches to target leukemias and solid tumors. With a background in leading commercial operations and developing corporate strategy in the pharmaceutical industry, Carlos has held various leadership positions at companies like Rocket Pharmaceuticals, Novartis Oncology, and Schering Plough Corporation. Carlos has a strong track record of driving revenue growth and leading successful teams across different regions and therapeutic areas. Carlos holds an MBA in Global and General Management from Thunderbird School of Global Management and has completed an Executive Education Program on General Management and Global Strategy from Columbia Business School.